<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
83270-003-01
</NDCCode>
<PackageDescription>
500 mg in 1 VIAL (83270-003-01)
</PackageDescription>
<NDC11Code>
83270-0003-01
</NDC11Code>
<ProductNDC>
83270-003
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Methohexital Sodium
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Methohexital Sodium
</NonProprietaryName>
<DosageFormName>
INJECTION
</DosageFormName>
<RouteName>
INTRAVENOUS
</RouteName>
<StartMarketingDate>
20241212
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA215488
</ApplicationNumber>
<LabelerName>
ONESOURCE SPECIALTY PHARMA LIMITED
</LabelerName>
<SubstanceName>
METHOHEXITAL SODIUM
</SubstanceName>
<StrengthNumber>
500
</StrengthNumber>
<StrengthUnit>
mg/500mg
</StrengthUnit>
<Pharm_Classes>
Barbiturate [EPC], Barbiturates [CS]
</Pharm_Classes>
<DEASchedule>
CIV
</DEASchedule>
<Status>
Active
</Status>
<LastUpdate>
2025-05-23
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20241212
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>